PEAK6 Investments’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,517
Closed -$27.3K 3636
2024
Q2
$27.3K Buy
2,517
+1,973
+363% +$24.3K ﹤0.01% 3237
2024
Q1
$7.62K Sell
544
-14,393
-96% -$187K ﹤0.01% 3756
2023
Q4
$157K Sell
14,937
-8,833
-37% -$79K ﹤0.01% 3374
2023
Q3
$217K Buy
23,770
+8,329
+54% +$74.7K ﹤0.01% 3021
2023
Q2
$112K Buy
+15,441
New +$133K ﹤0.01% 3187
2022
Q3
Sell
-15,441
Closed -$112K 5237
2022
Q2
$112K Buy
+15,441
New +$182K ﹤0.01% 5181

Other funds holding EOLS

PEAK6 Investments's EOLS Position: Q3 2024 in Review

PEAK6 Investments sold out of Evolus (EOLS) in Q3 2024, closing a stake of 2,517 shares — an estimated $27.3K sold.

PEAK6 Investments first reported a position in EOLS in Q2 2022 and held it in 6 quarters. The position peaked at $217K in Q3 2023. 165 funds tracked by Wall St. Rank hold EOLS as of Q3 2024.

  • PEAK6 Investments reported no remaining Evolus position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 2,517 Evolus shares in Q3 2024, an estimated $27.3K.
  • PEAK6 Investments first reported a position in Evolus in Q2 2022 and held it in 6 quarters.
  • PEAK6 Investments's Evolus position peaked at $217K in Q3 2023.
  • 165 funds tracked by Wall St. Rank held Evolus as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.